MetLife Investment Advisors »

Design Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $104k 19k 5.38
2024-06-30 $0 0 0.00
2023-06-30 $139k 22k 6.30
2023-03-31 $127k 22k 5.77
2022-12-31 $226k 22k 10.26
2022-09-30 $369k 22k 16.72
2022-06-30 $236k 17k 13.98
2022-03-31 $273k 17k 16.17
2021-12-31 $233k 11k 21.41